Ofatumumab

[Sar9,Met(O2)11]-Substance P TFA.

[Sar9,Met(O2)11]-Substance P TFA.

[Sar9,Met(O2)11]-Substance P TFA.

An irreversible inhibitor of TPPII commonly used at 10-100 &microM does not significantly interfere with the chymotrypsin-like activity of the proteasome also inhibits bleomycin hydrolase and puromycin-sensitive aminopeptidase when used at 50

An irreversible inhibitor of TPPII commonly used at 10-100 &microM does not significantly interfere with the chymotrypsin-like activity of the proteasome also inhibits bleomycin hydrolase and puromycin-sensitive aminopeptidase when used at 50

A potent inhibitor of VEGF receptors, inhibiting VEGFR1, 2, and 3 with IC₅₀ values of 130, 23, and 18 nM, respectively orally bioavailable in vivo, blocking VEGF-induced angiogenesis and preventing the growth of primary tumors and

AB-25E9 (anti-SIGLEC15) is a humanized monoclonal antibody targeting sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15). It may have potential as an anti-resorptive therapy for osteoporosis.

AB-25E9 (anti-SIGLEC15) is a humanized monoclonal antibody targeting sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15). It may have potential as an anti-resorptive therapy for osteoporosis.

AB-25E9 (anti-SIGLEC15) is a humanized monoclonal antibody targeting sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15). It may have potential as an anti-resorptive therapy for osteoporosis.

AB-25E9 (anti-SIGLEC15) is a humanized monoclonal antibody targeting sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15). It may have potential as an anti-resorptive therapy for osteoporosis.

ABC1183 is an orally active selective dual GSK3 and CDK9 inhibitor. ABC1183 inhibits GSK3β, GSK3α and CDK9/cyclin T1 with the IC 50 values of 657 nM, 327 nM and 321 nM, respectively. ABC1183 has anti-inflammatory and anti-tumor activitiesIn

ABC1183 is an orally active selective dual GSK3 and CDK9 inhibitor. ABC1183 inhibits GSK3β, GSK3α and CDK9/cyclin T1 with the IC 50 values of 657 nM, 327 nM and 321 nM, respectively. ABC1183 has anti-inflammatory and anti-tumor activitiesIn